On June 30, Albemarle rose 5.61% in pre-market trading, trading at approximately $135.84/share, with turnover of $2.2 million. The rebound follows a sharp selloff that saw shares plunge over 15% from approximately $157 to $134 in the prior week amid broad lithium sector weakness.

On the news front, Jefferies adjusted its price target on Albemarle from $244 to $211 while maintaining a Buy rating, with the revised target still implying approximately 55% upside from current levels. According to FactSet, the consensus analyst average target stands at $218.37, with Citi, RBC, UBS, and other major institutions maintaining Buy or Outperform ratings with targets ranging from $211 to $264 — all significantly above the current share price.

Notably, Citi upgraded Albemarle to Buy from Neutral on June 22 with a $225 target, while RBC raised its target to $245 in late April maintaining an Outperform rating. The concentrated bullish institutional consensus appears to be providing a floor for the stock following its recent correction, as investors reassess the lithium sector outlook.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)